PDH Beijing Joint Venture Profit Distribution

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 31, 2011) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

Premier Diagnostic Health Service Inc. ("PDH")(CNSX:PDH) today announced that its joint venture in Beijing, China, is now distributing profits to PDH's corporate head office in return for past investment to setup the MRI clinic.

The Beijing joint venture was launched in Fall 2010 with an initial scan rate of approximately 40 per month. The current scan rate now exceeds 600 scans per month as confirmed on Denis Tusar's, PDH Chairman, recent business trip to China.

PDH has received an initial profit distribution, net of capital repayment, and has setup a regular payment schedule that navigates appropriate Chinese import/export rules.

"Establishing strong relationships and the methods to generate a return are crucial milestones to implementing PDH's business plan and we're excited to be moving forward onto our next milestones," said Denis Tusar.

More details about PDH's new business plan are available on the company's website www.premierdiagnostics.ca.

The Canadian National Stock Exchange has neither approved nor disapproved the contents of this press release. Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier.

About Premier Diagnostic Health Services Inc. ("PDH")

Premier is a Canadian company accelerating international access to advanced medical diagnostic tools and skills. The company's vision is to provide services and partnership opportunities that support "improving medical decisions" around the world. The company's approach involves building long-term relationships covering management, quality, and financial services that are necessary to build, operate, and grow hospitals' diagnostic capacity and capability.